MPM BioImpact
Venture capital · Boston, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio2 active
3Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Arialys Therapeutics
16Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Arialys Therapeutics | Biotech | Active | Jul 1, 2025 | $29.1M |
| Valora Therapeutics | Biotech | Active | Jul 24, 2024 | $13.0M |
| Cidara Therapeutics | Biotech | Acquired | May 6, 2024 | $349.1M |
| Translate Bio | Biotech | Acquired | May 10, 2019 | $98.5M |
| Aldeyra Therapeutics | Biotech | Public | Feb 11, 2019 | $24.6M |
Peer ranks
Portfolio size#81
Portfolio exits#69
Raises, 12 months#88
Co-investors#128
Co-investors
- MPM CapitalVenture capital4 shared
- Avalon VenturesVenture capital3 shared
- Clarus VenturesVenture capital1 shared
- Domain AssociatesVenture capital1 shared
- Gurnet Point CapitalVenture capital1 shared
- H.I.G. BioHealth PartnersVenture capital1 shared
- ModernaVenture capital1 shared
- New Enterprise AssociatesVenture capital1 shared
- Omega FundsVenture capital1 shared
- RA CapitalVenture capital1 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.